Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elderberry Extract for Influenza Treatment
NCT03410862Phase 4Completed
- Start
- Jan 2018
- Primary completion
- Jun 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in influenza (2 arms). Primary endpoints: Number of Days Until Alleviation of Flu Symptoms Post Treatment at 21 days and Number of Days Until Complete Resolution of All Flu Symptoms for 24 Hours at 21 days. Started Jan 2018; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT03410862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410862.